🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMy fatty liver reversal — November 2025 Page 7

My fatty liver reversal — November 2025

rachel_ABQ Mon, Dec 15, 2025 at 11:22 AM 33 replies 1,345 viewsPage 7 of 7
KarenAZ_mom
Member
567
2,567
Aug 2024
Scottsdale, AZ
Dec 28, 2025 at 9:05 AM#31

Following on from NurseAsh_DET — and this may be the naive question:

Did your prescriber agree with that reading, and if not what was their objection?

10 8anna.melb_AU, mark_tokyo, hans_munich and 7 others
Reply Quote Save Share Report
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
Dec 28, 2025 at 11:34 PM#32
rachel_ABQ said:
What actually changed my mind was the point about waiting for a trend instead of reading a single measurement, which is embarrassing in hindsight and…

This is where I part company with the consensus forming above. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.

11 9hyun_seoul, jim_asheville, matt_MKE and 8 others
Reply Quote Save Share Report
fiona_VT
Member
178
890
Dec 2024
Vermont
Dec 29, 2025 at 2:03 PM#33
rachel_ABQ said:
What actually changed my mind was the point about waiting for a trend instead of reading a single measurement, which is embarrassing in hindsight and…

Agreed, and the size of the effect matters as much as its existence. Something real and small gets treated here as though it were real and decisive.

12 10jason_sac26, chris_chi24, tampaLisa73 and 9 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
emily_PDX
Member
245
1,123
Nov 2024
Portland, OR
Dec 30, 2025 at 4:32 AM#34
rachel_ABQ said:
What actually changed my mind was the point about waiting for a trend instead of reading a single measurement, which is embarrassing in hindsight and…

Thank you for spelling out the reasoning rather than just the conclusion. Adding it to my notes with a link back to this thread.

13 11Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 10 others
Reply Quote Save Share Report
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Dec 30, 2025 at 7:00 PM#35

From the other side of the consultation, briefly. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

14 12JessicaM_2024, TomFromTexas, mike.trainer_LA and 11 others
Reply Quote Save Share Report
1567

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register